Melinda Bachini
About
In The Last Decade
Melinda Bachini
13 papers receiving 829 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Surgery 687
- Oncology 426
- Pulmonary and Respiratory Medicine 357
- Molecular Biology 136
- Cancer Research 118
Countries citing papers authored by Melinda Bachini
This map shows the geographic impact of Melinda Bachini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Bachini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Bachini more than expected).
Fields of papers citing papers by Melinda Bachini
This network shows the impact of papers produced by Melinda Bachini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Bachini. The network helps show where Melinda Bachini may publish in the future.
Co-authorship network of co-authors of Melinda Bachini
This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Bachini. A scholar is included among the top collaborators of Melinda Bachini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Bachini. Melinda Bachini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial breakdown → | 51 |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | Cholangiocarcinoma breakdown → | 463 |
| 14 | 8 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline breakdown → | 285 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.